IL68422A0 - Hydantoin derivatives and their use in medicine - Google Patents

Hydantoin derivatives and their use in medicine

Info

Publication number
IL68422A0
IL68422A0 IL68422A IL6842283A IL68422A0 IL 68422 A0 IL68422 A0 IL 68422A0 IL 68422 A IL68422 A IL 68422A IL 6842283 A IL6842283 A IL 6842283A IL 68422 A0 IL68422 A0 IL 68422A0
Authority
IL
Israel
Prior art keywords
medicine
hydantoin derivatives
chromanimidazolidine
methythio
methylsulfinyl
Prior art date
Application number
IL68422A
Other languages
English (en)
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of IL68422A0 publication Critical patent/IL68422A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL68422A 1982-04-15 1983-04-15 Hydantoin derivatives and their use in medicine IL68422A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/368,629 US4464385A (en) 1982-04-15 1982-04-15 Treatment of diabetic complications with hydantoins

Publications (1)

Publication Number Publication Date
IL68422A0 true IL68422A0 (en) 1983-07-31

Family

ID=23452055

Family Applications (1)

Application Number Title Priority Date Filing Date
IL68422A IL68422A0 (en) 1982-04-15 1983-04-15 Hydantoin derivatives and their use in medicine

Country Status (15)

Country Link
US (1) US4464385A (xx)
EP (1) EP0092386B1 (xx)
KR (1) KR890000156B1 (xx)
AT (1) ATE36333T1 (xx)
AU (1) AU552937B2 (xx)
CA (1) CA1201715A (xx)
DE (1) DE3377650D1 (xx)
ES (3) ES521445A0 (xx)
GR (1) GR78183B (xx)
IE (1) IE55227B1 (xx)
IL (1) IL68422A0 (xx)
NZ (1) NZ203875A (xx)
PT (1) PT76551B (xx)
WO (1) WO1983003542A1 (xx)
ZA (1) ZA832491B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540700A (en) * 1982-04-15 1985-09-10 Alcon Laboratories, Inc. Treatment of diabetic complications with certain spiro-imidazolidine-diones
JPH0772190B2 (ja) * 1985-02-26 1995-08-02 エーザイ株式会社 ヒダントイン誘導体
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―３―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2716648A (en) * 1955-08-30 Hydantoin derivatives
US2683718A (en) * 1952-01-11 1954-07-13 Searle & Co Spiro-[xanthene-9, 4'-imidazolidine]-2, 5-dione
US3349124A (en) * 1957-05-20 1967-10-24 Pfizer & Co C Oral antidiabetic agent
DE1135915B (de) * 1961-06-29 1962-09-06 Asta Werke Ag Chem Fab Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4209630A (en) * 1976-10-18 1980-06-24 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4147795A (en) * 1977-02-11 1979-04-03 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4127665A (en) * 1978-01-18 1978-11-28 Pfizer Inc. Thienohydantoin derivatives
US4147797A (en) * 1978-08-11 1979-04-03 Pfizer Inc. Spiro-furanohydantoin derivatives
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4181728A (en) * 1978-11-16 1980-01-01 Pfizer Inc. Spiro-polycyclicimidazolidinedione derivatives
US4327107A (en) * 1979-02-06 1982-04-27 A. H. Robins Company, Inc. Method useful in the treatment of sugar cataracts using 4-substituted-2-iminoimidazolidine compounds
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
US4307108A (en) * 1979-12-26 1981-12-22 Pfizer Inc. Method for lowering sorbitol levels using spiro-imides
JPS5899480A (ja) * 1981-12-04 1983-06-13 Senjiyu Seiyaku Kk 新規クロマン誘導体

Also Published As

Publication number Publication date
EP0092386A3 (en) 1985-03-06
ES8602799A1 (es) 1985-12-01
ES8500951A1 (es) 1984-11-01
EP0092386A2 (en) 1983-10-26
NZ203875A (en) 1985-12-13
ES538137A0 (es) 1985-12-01
PT76551A (en) 1983-05-01
GR78183B (xx) 1984-09-26
CA1201715A (en) 1986-03-11
IE830836L (en) 1983-10-15
KR890000156B1 (en) 1989-03-08
ES8507552A1 (es) 1985-09-01
US4464385A (en) 1984-08-07
IE55227B1 (en) 1990-07-04
ES521445A0 (es) 1984-11-01
ATE36333T1 (de) 1988-08-15
WO1983003542A1 (en) 1983-10-27
ES538138A0 (es) 1985-09-01
AU552937B2 (en) 1986-06-26
ZA832491B (en) 1983-12-28
KR840004431A (ko) 1984-10-15
AU1325883A (en) 1983-10-20
DE3377650D1 (en) 1988-09-15
EP0092386B1 (en) 1988-08-10
PT76551B (en) 1986-01-21

Similar Documents

Publication Publication Date Title
PH23014A (en) Novel insulin derivatives,their use and pharmaceutical agents for the treatment of diabetes mellitus
JPS5791915A (en) Novel lipid composition useful for dietetics, resuscitation and treatment
IL62847A (en) Pharmaceutical composition for the treatment of juvenile diabetes mellitus comprising insulin and l-carnitine and/or an l-acylcarnitine
YU190881A (en) Device for treating blood outside the body
AU553269B2 (en) 2,3-diaryl-5-halo thiophenes
EP0167995A3 (en) (pyrrol-1-yl)-phenyl-dihydropyridazinones, their preparation and use
NO894008L (no) Trekonserveringsmiddel og fremgangsmaate for behandling avtre med samme.
IL68422A0 (en) Hydantoin derivatives and their use in medicine
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
ZA88922B (en) Use of oxoquinazoline derivatives in the treatment of hyperuricaemia
HK44597A (en) Use of chlormethiazole in the manufacture of a medicament for the prevention and/or treatment of neurodegeneration
IL89901A0 (en) Strobilurine derivatives
JPS54128183A (en) Hollow body for medical treatment or food
ZA825302B (en) Medicine for the treatment of diabetes
GR3005231T3 (xx)
NO832332L (no) Anordning for kombinert terapeutisk og stimulativ behandling av gummene.
GB9010190D0 (en) Composition for the treatment of protozoal disease and their use
AU1705783A (en) Medicine for the treatment of the neoplazic disease
DE3366025D1 (en) Medicine for the treatment of the neoplazic disease
IT1273565B (it) Uso della s-benzoilossimetiltiamina nel trattamento del diabete mellito
IL83633A0 (en) Device for the treatment of the skin
IL47027A0 (en) Improvements in surgical pads for bandaging and absorption of liquids from the body

Legal Events

Date Code Title Description
RH Patent void